ClearPoint Neuro, Inc. Quarterly report [Sections 13 or 15(d)]

Quarterly report [Sections 13 or 15(d)]

Subsequent Events

Subsequent Events	6 Months Ended
Jun. 30, 2026
Subsequent Events [Abstract]
Subsequent Events	12. Subsequent Events Operating Leases On July 8, 2026, the Company entered into an amendment to the sublease for its office space in Solana Beach, California, under which the term of the sublease was extended by an additional five years to December 31, 2031. The Company estimates it will recognize an incremental right-of-use asset and corresponding lease liability of approximately $2.3 million, reflecting the extended lease term. On July 13, 2026, the final phase of the Company's lease for its ClearPoint Advanced Laboratories (the “CAL”) facility located in San Diego, California, became available for its intended use. The Company estimates it will recognize a right-of-use asset and corresponding lease liability of approximately $6.7 million. See Note 9 above for additional information regarding the Company's leases. Purchase Commitments Subsequent to June 30, 2026, the Company issued purchase orders for capital equipment totaling approximately $3.1 million. Delivery of the equipment is expected in 2027, with payments due through 2028.

Subsequent Events

6 Months Ended

Jun. 30, 2026

Subsequent Events [Abstract]

Subsequent Events

12.

Subsequent Events

Operating Leases

On July 8, 2026, the Company entered into an amendment to the sublease for its office space in Solana Beach, California, under which the term of the sublease was extended by an additional five years to December 31, 2031. The Company estimates it will recognize an incremental right-of-use asset and corresponding lease liability of approximately $2.3 million, reflecting the extended lease term.

On July 13, 2026, the final phase of the Company's lease for its ClearPoint Advanced Laboratories (the “CAL”) facility located in San Diego, California, became available for its intended use. The Company estimates it will recognize a right-of-use asset and corresponding lease liability of approximately $6.7 million.

See Note 9 above for additional information regarding the Company's leases.

Purchase Commitments

Subsequent to June 30, 2026, the Company issued purchase orders for capital equipment totaling approximately $3.1 million. Delivery of the equipment is expected in 2027, with payments due through 2028.